Back to Atlas
CTransientStandard research/education caution
CMP-0380
Supplement/research
Luteolin
Senomorphic / Anti-SASP
Anti-inflammatory and neuroprotective positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Flavone
- Primary mechanism
- NF-κB, JAK/STAT and inflammatory signaling modulation
- Primary market use
- Longevity / neuroinflammation
Pharmacology
- Molecular weight (Da)
- 286.24
- Oral bioavailability
- Oral; low/variable
- Half-life
- Not well established
- Route tags
- Route-dependent / verify
- Evidence level
- Preclinical/Human supplement
- Clinical status
- Supplement/research
- Value-for-money score
- 5 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Likely senomorphic rather than senolytic; requires ongoing exposure